Status:
COMPLETED
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
Eligibility:
All Genders
Brief Summary
To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori
Eligibility Criteria
Inclusion
- Inclusion criteria:
- gastric low-grade mucosa-associated lymphoid tissue (MALT) lymphoma with Helicobacter pylori positive
- The stages of MALT lymphoma are Lugano International Conference classification Stage I or II 1 and Wotherspoon grade 4 or 5
- Exclusion criteria:
- With diffuse large B-cell lymphoma
- Have been treated to gastric mucosa-associated lymphoid tissue (MALT) lymphoma
- Corresponding to contraindication of each drug
Exclusion
Key Trial Info
Start Date :
January 13 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 17 2016
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01264822
Start Date
January 13 2011
End Date
November 17 2016
Last Update
February 27 2017
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya, Aichi-ken, Japan
2
Hirosaki, Aomori, Japan
3
Kashiwa, Chiba, Japan
4
Matsuyama, Ehime, Japan